The Asia Pacific N-Bromosuccinimide Market would witness market growth of 3.2% CAGR during the forecast period (2024-2031). In the year 2022, the Asia Pacific market's volume surged to 167.61 tonnes, showcasing a growth of 12.1% (2020-2023).
N-Bromosuccinimide (NBS) finds significant applications in the pharmaceutical industry due to its ability to selectively brominate organic compounds under mild conditions. One of its key applications is in the synthesis of pharmaceutical intermediates and active ingredients. For instance, NBS can be used to brominate specific positions in drug molecules, altering their properties and enhancing their therapeutic efficacy. This selective bromination is crucial in pharmaceutical research and development, where precise modifications to molecular structures are often required to optimize drug activity and reduce side effects. Thus, the pharmaceutical industries in China consumed 23.68 tonnes of this chemical in 2023.
The China market dominated the Asia Pacific N-Bromosuccinimide Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $3,474.4 Thousands by 2031. The Japan market is registering a CAGR of 2.9% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 3.6% during (2024 - 2031).
The N-bromosuccinimide market is influenced by several trends reflecting advancements in synthetic methodologies, regulatory landscapes, and market dynamics. For instance, growing awareness of environmental sustainability is driving the adoption of green chemistry principles in chemical synthesis, including NBS-mediated reactions. Manufacturers and researchers are exploring greener alternatives and sustainable reaction conditions to minimize waste generation, reduce energy consumption, and utilize renewable resources. Green chemistry initiatives aim to develop eco-friendly synthetic routes that prioritize efficiency, safety, and environmental stewardship in NBS-based processes.
Likewise, there is increasing emphasis on process intensification strategies to enhance the efficiency and sustainability of N-Bromosuccinimide synthesis and utilization. Continuous flow reactors, microreactors, and other innovative reactor technologies are being explored to streamline NBS-mediated reactions and improve reaction control, scalability, and safety. Process intensification aims to optimize resource utilization, minimize reaction times, and maximize product yields in NBS-based processes.
As China's pharmaceutical industry continues to expand, there is a growing demand for NBS as a key reagent in the synthesis of pharmaceutical intermediates. According to the International Trade Administration (ITA), China’s pharmaceutical sector has constantly grown and reached $161.8 billion in 2023, taking about 30% of the global industry share. Similarly, as the chemical industry in India expands, there is a growing demand for NBS as a key reagent in various chemical processes, including pharmaceutical synthesis, polymer modification, and specialty chemical manufacturing. As per the National Investment Promotion & Facilitation Agency, the size of chemicals & petrochemicals sector in India is around $215 Bn, expected to grow to $300 Bn by 2025. Production of organic chemicals has increased (Up to Aug 2023) as compared to the corresponding period of the previous year, recording an increase of 4.52%. Hence, the increasing pharmaceutical industry and rising chemical sector is driving the growth of the market.
Based on Content, the market is segmented into Content 99%, and Content 98%. Based on Application, the market is segmented into Pharmaceutical Industry, Pesticides Industry, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
N-Bromosuccinimide (NBS) finds significant applications in the pharmaceutical industry due to its ability to selectively brominate organic compounds under mild conditions. One of its key applications is in the synthesis of pharmaceutical intermediates and active ingredients. For instance, NBS can be used to brominate specific positions in drug molecules, altering their properties and enhancing their therapeutic efficacy. This selective bromination is crucial in pharmaceutical research and development, where precise modifications to molecular structures are often required to optimize drug activity and reduce side effects. Thus, the pharmaceutical industries in China consumed 23.68 tonnes of this chemical in 2023.
The China market dominated the Asia Pacific N-Bromosuccinimide Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $3,474.4 Thousands by 2031. The Japan market is registering a CAGR of 2.9% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 3.6% during (2024 - 2031).
The N-bromosuccinimide market is influenced by several trends reflecting advancements in synthetic methodologies, regulatory landscapes, and market dynamics. For instance, growing awareness of environmental sustainability is driving the adoption of green chemistry principles in chemical synthesis, including NBS-mediated reactions. Manufacturers and researchers are exploring greener alternatives and sustainable reaction conditions to minimize waste generation, reduce energy consumption, and utilize renewable resources. Green chemistry initiatives aim to develop eco-friendly synthetic routes that prioritize efficiency, safety, and environmental stewardship in NBS-based processes.
Likewise, there is increasing emphasis on process intensification strategies to enhance the efficiency and sustainability of N-Bromosuccinimide synthesis and utilization. Continuous flow reactors, microreactors, and other innovative reactor technologies are being explored to streamline NBS-mediated reactions and improve reaction control, scalability, and safety. Process intensification aims to optimize resource utilization, minimize reaction times, and maximize product yields in NBS-based processes.
As China's pharmaceutical industry continues to expand, there is a growing demand for NBS as a key reagent in the synthesis of pharmaceutical intermediates. According to the International Trade Administration (ITA), China’s pharmaceutical sector has constantly grown and reached $161.8 billion in 2023, taking about 30% of the global industry share. Similarly, as the chemical industry in India expands, there is a growing demand for NBS as a key reagent in various chemical processes, including pharmaceutical synthesis, polymer modification, and specialty chemical manufacturing. As per the National Investment Promotion & Facilitation Agency, the size of chemicals & petrochemicals sector in India is around $215 Bn, expected to grow to $300 Bn by 2025. Production of organic chemicals has increased (Up to Aug 2023) as compared to the corresponding period of the previous year, recording an increase of 4.52%. Hence, the increasing pharmaceutical industry and rising chemical sector is driving the growth of the market.
Based on Content, the market is segmented into Content 99%, and Content 98%. Based on Application, the market is segmented into Pharmaceutical Industry, Pesticides Industry, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Nanjing Suru Chemical Co., Ltd.
- SAMUH LAXMI CHEMICALS (BOM) P. LTD. (Anron Chemicals Co. Group)
- Purecha Group
- Jiangxi Dasuo Chemical Co., Ltd.
- Resins and Allied Products
- Zhejiang Kente Catalysts Technologies Co., Ltd.
- HALIDES CHEMICALS PVT. LTD.
- Mody Chemi-Pharma Limited
Market Report Segmentation
By Content (Volume, Tonnes, USD Million, 2020-31)- Content 99%
- Content 98%
- Pharmaceutical Industry
- Pesticides Industry
- Others
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific N-Bromosuccinimide Market by Content
Chapter 5. Asia Pacific N-Bromosuccinimide Market by Application
Chapter 6. Asia Pacific N-Bromosuccinimide Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Nanjing Suru Chemical Co., Ltd.
- SAMUH LAXMI CHEMICALS (BOM) P. LTD. (Anron Chemicals Co. Group)
- Purecha Group
- Jiangxi Dasuo Chemical Co., Ltd.
- Resins and Allied Products
- Zhejiang Kente Catalysts Technologies Co., Ltd.
- HALIDES CHEMICALS PVT. LTD.
- Mody Chemi-Pharma Limited
Methodology
LOADING...
